Rabbit Polyclonal ILP2 antibody. Suitable for ICC, WB and reacts with Human samples. Cited in 8 publications. Immunogen corresponding to Synthetic Peptide within Human BIRC8 aa 1-50.
View Alternative Names
ILP2, BIRC8, Baculoviral IAP repeat-containing protein 8, Inhibitor of apoptosis-like protein 2, Testis-specific inhibitor of apoptosis, IAP-like protein 2, ILP-2
- ICC
Unknown
Immunocytochemistry - Anti-ILP2 antibody (AB9664)
ab9664 at 10μg/ml staining ILP2 in HepG2 cells by Immunocytochemistry.
- WB
Supplier Data
Western blot - Anti-ILP2 antibody (AB9664)
All lanes:
Western blot - Anti-ILP2 antibody (ab9664) at 1 µg/mL
Lane 1:
HepG2 cell lysate
Lane 2:
MOLT4 cell lysate
Predicted band size: 27 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein functions by preventing cell death providing essential support for cellular survival. ILP2 is part of a complex that includes other IAPs and operates in the regulation of apoptosis. Its action directly inhibits caspases which are enzymes critical for the execution phase of cell apoptosis. This function is significant as it contributes to the balance between cell proliferation and death making ILP2 an important player in cellular homeostasis.
Pathways
The protein acts in critical signaling pathways related to cell survival and apoptosis like the NF-kB signaling pathway. ILP2 works in conjunction with proteins such as XIAP and c-IAP1 which participate in similar pathways contributing to protection against unwanted cell death. This involvement helps maintain normal cellular processes and supports proper functioning of tissues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Molecular medicine reports 25: PubMed35039877
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1006 PubMed34345288
2021
Applications
Unspecified application
Species
Unspecified reactive species
eLife 10: PubMed33620316
2021
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 34:10531-10546 PubMed32543747
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 130:2054-2068 PubMed32175920
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 10:4625 PubMed32170161
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 17:4687-4692 PubMed31086602
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 40:2047-2055 PubMed30106449
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com